A high performance liquid chromatographic (HPLC) method for the analysis of ketorolac tromethamine and its associated impurities was examined with the aim of reducing analysis times while maintaining good efficiency. The separation was carried out using a waters X-bridge -C8 (3mm x75mm, 2.5µm particle size) column with a mobile phase of tetrahydrofuran -ammonium dihydrogen phosphate (0.05M, pH3, 28:72 v/v) at a flow rate of 1.7mL/min and UV detection at 313nm. The method was validated according to ICH (international conference on harmonisation) guidelines with respect to precision, accuracy, linearity, specificity, robustness and limits of detection and quantification. All parameters examined were found to be well within the stated guidelines. Naturally aged samples were also tested to determine sample stability. A profile of sample and impurity breakdown was presented. A three-fold reduction in analysis time was achieved in comparison with the current approved EP (european pharmacopeia) method and the method can be immediately used for routine assay and related substance determination.
INTRODUCTION
Ketorolac trometamol, 2-Amino-2-(hydroxymethyl) propane-1, 3-diol (1RS) -5-benzyl-2, 3-dihydro-1H-pyrrolizine-1-carboxylate (API) (European Pharmacopoeia 2008) ( Fig..1A) is a non-steroidal anti-inflammatory drug (NSAID). It is a member of the heterocyclic acetic acid derivative family and is used as an analgesic with an efficacy close to that of the opioid family (Rang et al., 2007) . It is also a potent antipyretic and anti-inflammatory. It is mainly used for the short term treatment of post-operative pain as it is highly selective for the COX-1 enzyme (Wang et al., 2001) . Treatment is begun with an injection and oral use is only permitted when the patient is able to eat and drink. Its main impurities are (±) -6-Benzoyl -1,2-dihydro-1H-pyrrolizine-1-carboxylic acid (Impurity 1) (Fig.1b) , (±) -5-Benzoyl -2,3-dihydro-1-hydroxy-1H-pyrrolizine-1 (Impurity 2) (Fig.1c) and 5-Benzoyl -2,3-dihydro-1H-pyrrolizine-1-one, (±) -5-Benzoyl -2,3-dihydro-1-hydroxy-1H-pyrrolizine-1 (Impurity 3) (Fig.1d ).
There are a number of methods described in the literature for the analysis of ketorolac in biological samples, such as plasma (Tsina et al., 1996) and serum (Chaudhary et al., 1993) , by HPLC (Jones et al., 1994 ) (Wu et al., 1990 ) (Ing-Lorenzini et al. 2009 ) as well as the use of other analytical chromatographic techniques such as TLC (Devarajan et al., 2000) and capillary electrochromatography (Orlandini et al., 2004) . These are often complicated and time-consuming methods or cannot be used for the simultaneous determination of the API and its impurities.
High performance liquid chromatography (HPLC) is widely known to be one of the most important analytical techniques used in the pharmaceutical industry. Many monographs in the european pharmacopeia (Ph.Eur) report the use of chromatographic methods for the analysis of pharmaceutical substances. There has been much emphasis recently, on reducing analysis time and solvent consumption in HPLC. The advances in column technology and the introduction of a number of commercially available ultra high performance liquid (UPLC) chromatographs, has permitted this reduction. Many reports have shown the advantages of using these smaller particle shorter columns (Dongre et al., 2008) , including the reduction in analysis times while maintaining or increasing resolution, and the sensitivity and selectivity have been increased (De Villiers et al., 2006) (Wren et al., 2006) (Guillarme et al., 2006) . This improvement in speed and sensitivity is useful in all areas of the pharmaceutical process.
The aim of this research was to achieve a faster separation of ketorolac tromethamine and three main impurities in the bulk substance. An isocratic method was developed and validated according to ICH guidelines.
MATERIALS AND METHODS

Materials and reagents
Samples of ketorolac tromethamine and three impurities were received from Roche Pharmaceutical Inc., Clarecastle, Ireland. HPLC-grade tetrahydrofuran (THF) was purchased from Sigma Aldrich. Reagent-grade ammonium dihydrogen phosphate was obtained from BDH laboratories.
Ultra-pure water was obtained by Millipore milli Q water purification system.
Instrumentation
The system used was an Agilent 1200 rapid resolution liquid chromatograph with a 1200 series binary pump SL and vacuum degasser, a 1200 series high-performance auto-sampler, a 1200 series thermostatted column compartment SL, a 1200 Series DAD SL for up to 80 Hz operation which were controlled by chemstation B.02.01.SR1 data acquisition and evaluation software. The column used was a waters X-bridge C8 column (75mm x 3mm i.d., 2.5µm particle size). Evaluation of an Agilent, Zorbax SB-C8, 1.8 µm column was also conduction.
Chromatographic conditions
An isocratic separation was carried out using a mobile phase consisting of THF-ammonium dihydrogen phosphate (pH3 0.05M) (28:72 v/v) was used at a flow rate of 1.7ml/min with UV detection at 313nm. The column was heated to 44°C and an injection volume of 3µl was used. The mobile phase was filtered through 0.45µm nylon filters and degassed in an ultrasonic bath prior to use.
Sample preparation
A standard solution (40µg/ml) of the ketorolac tromethamine and the three impurities was prepared using THFUltrapure water (28:72 v/v) as the diluents. A high range linearity standard solutions (7 standards), containing only the API, were prepared from an 1000µg/mL stock solution over a range of 200-800µg/mL.
A low range solutions (7 standards), containing only the impurities, were prepared from a 2µg/mL stock solution over a range of 0.22 -1.54µg/mL.
RESULTS AND DISCUSSION
Method development and optimisation
Initially, as detailed in the Ph. Eur, a waters spherisorb C8 column (250mm x 4.6mm i.d., 5µm particle size) maintained at 40°C was used for the determination of ketorolac tromethamine and its impurities. The flow rate of 1.5mL/min eluted the active ingredient in 9.12mins. After a review of the columns available, a waters X-bridge 2.5 µm column was decided upon. For method optimisation, a systematic examination of the mobile phase composition and flow rate was conducted. The flow rate and temperature were increased in increments taking retention times, as well as the resolution between the API and impurity 3 and the pressure into account. An isocratic method using THF-ammonium dihydrogen phosphate (pH3 0.05M) (28:72 v/v), with a flow rate of 1.7mL/min at a temperature of 44°C was found to give a retention time of between 2-3 minutes with satisfactory resolution between all peaks. The detection wavelength was kept constant, as was the pH. As theory suggests, the smaller particles allowed the use of higher flow rates without loss of efficiency, and resolution and peak symmetry were improved. The order of elution was, impurity 1, impurity 2, impurity 3 followed by the API ketorolac tromethamine. A comparison of the run times and chromatography between the original and new methods is shown in Fig. 2 .
Validation
The method was validated with respect to parameters, laid out by the international conference on harmonisation (ICH 2002), including linearity, precision, accuracy, specificity, LOD, and LOQ.
Linearity
Each of the impurities and the API gave a linear response over the concentration ranges tested. The mean values of the slope, intercept and correlation co-efficient are given in Fig. 3-6 . The impurities were run at a low concentration range 0.22 to 1.54µg/mL while the active ingredient ketorolac tromethamine was run at a high standard range 200 to 800µg/mL. The ICH guidelines state that a correlation co-efficient of 0.99 or over is desirable for linearity studies. All curves had values within this range showing there is a linear relationship across the range for the analytical procedure.
Accuracy
The percent recovery of the linearity samples were calculated and are shown in Table 1 . Good recoveries were obtained ranging from 98.83 to 100.22% for the API. The percent relative error was also calculated for each concentration giving RSD values of 0.39 and 1.16% for the API. 
LOQ and LOD
The LOQ and LOD were determined based on signal-tonoise ratios, where the analytical responses of approximately 10 and 3, respectively, were used. The concentrations found are seen in Table 2. A chromatogram for the LOQ for ketrolac tromethamine can be seen in Fig. 7 . 
Precision
Repeatability studies were performed by injecting 6 replicates of the API test solution (0.4mg/mL). Repeatability studies on the impurities were performed by injecting 6 replicates of a 4µg/mL standard of the individual impurities. The %RSD values were found to range between 0.43% and 5.56% (Table 3) . Results met with the test specifications for the API (1.5%) and the acceptable limit of 10% for the impurities. 
Selectivity
Samples of each of the separate impurities were prepared and injected 6 times. A ketorolac tromethamine sample was also injected. All samples had different retention times. The test solution was also injected. All peaks were sufficiently separated and no interference was noted.
Sample Stability
The stability of the samples, stored in clear and amber glassware in ambient temperatures, and in clear glassware in the fridge (4ºC) was tested at five intervals; immediately, after one day, after 7 days, after 28 days and after 42 days. No degradation of the samples occurred under any of the conditions for the first 7 days. Degradation products were seen in the samples stored in the clear glassware at ambient temperatures after 4 weeks. No degradation products were seen in the samples stored in the other conditions. Chromatograms from the clear ambient sample from day 1, day 28 and day 42 are shown in Fig. 8A , B and C.
Method Robustness
Wavelength, pH and mobile phase composition were varied to determine the robustness of the method experimental conditions. At the pH of 2.5 all impurities and the active ingredient were separated but resolution suffered slightly. At the pH of 3, impurity 3 and Ketorolac tromethamine were co-eluting. When the mobile phase was varied, the resolution at 70:30 between the impurity 1 and impurity 2 and the resolution between impurity 3 and ketorolac tromethamine was slightly less than 1.5. At 74:26 the resolution was satisfactory but the retention time was lengthened. There was no noticeable difference between the chromatograms when the wavelength was varied by ±2 nm.
Sub 2 µm Column Method
A review of suitable sub 2 µm packed columns was also undertaken in order to further reduce the time for analysis. An Agilent, zorbax SB-C8, 1.8 µm, 4.6 mm (i.d.) x 50 mm column was found to be suitable giving good resolution between peaks (greater than 1.8), together with reducing the elution time of the individual peaks. The gradient program for this analysis can be seen in Table 4 with the resultant chromatographic plot seen in Fig.  9 . The chromatographic conditions for this analysis utilises a THFammonium dihydrogen phosphate (pH3 0.05M) mobile phase with gradient elution at a flow rate of 2ml/min with UV detection at 313nm. The column was heated to 40°C and an injection volume of 3µl was used. The mobile phase was filtered through 0.45µm nylon filters and degassed in an ultrasonic bath prior to use. The use of a sub 2µm column allows for the shortest elution time for ketrolac tromethamine and its impurities, however at least 5 minutes of a equilibration time is required after the elution of the final peak resulting in an overall greater sample analysis time. 
CONCLUSION
A rapid HPLC method for the determination of ketorolac tromethamine and its main production impurities was developed and validated. It was found that the analysis times could be reduced three-fold in comparison with the current approved European Pharmacopeia method. This is achieved while maintaining resolution and good efficiency. The method was proven to be accurate, precise and capable of satisfactorily separating all impurities in under three minutes. Basic stability studies showed that the samples can be stored without degradation for a period of up to 7 days in clear glassware and up to 42 days in amber glassware. It can be used for the routine analysis of ketorolac tromethamine and its related impurities in bulk API form. Furthermore the lower solvent consumption along with the significantly reduced run time leads to an environmentally friendly economically analytical procedure that allows for the analysis of a large number of samples over a short period of time. 
